China SXT Pharmaceuticals (SXTC)
Manufacturer of Suxuantang traditional Chinese medicine pieces for Chinese hospitals, wholesalers and pharmacy chains.
Univest Securities, LLC Announces Closing of $9 Million Registered Direct Offering for its Client China SXT Pharmaceuticals Inc. (NASDAQ: SXTC)
New York, July 24, 2026 (GLOBE NEWSWIRE) -- Univest Securities, LLC ("Univest"), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the "Offering") of approximately $9 million for its client China SXT Pharmaceuticals Inc.
Univest Securities, LLC Announces Closing of $9 Million Registered Direct Offering for its Client China SXT Pharmaceuticals Inc. (NASDAQ: SXTC)
New York, July 24, 2026 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the “Offering”) of approximately $9 million for its client China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) (the "Company"), a China-based innovative pharmaceutical company focusing on the research, development, manufacture, marketing and sales of traditional Chinese medicine pieces.
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Down 37.4% in June
China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC - Get Free Report) was the recipient of a significant drop in short interest during the month of June. As of June 30th, there was short interest totaling 45,019 shares, a drop of 37.4% from the June 15th total of 71,896 shares. Based on an average daily volume of 50,754
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Down 29.1% in February
China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC - Get Free Report) was the target of a significant drop in short interest during the month of February. As of February 27th, there was short interest totaling 52,570 shares, a drop of 29.1% from the February 12th total of 74,183 shares. Based on an average trading volume of 72,335
Univest Securities, LLC Announces Closing of $10 Million Registered Direct Offering for its Client China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC)
New York, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the “Offering”) of approximately $10 million for its client China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (the “Company” or “China SXT”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements (“TCMHS”).
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC AI INSIGHTS INITIATIVE TO OPTIMIZE TRADITIONAL CHINESE MEDICINE PORTFOLIO, ENHANCE MARKET ANALYSIS AND EXPLORE AI-SUPPORTED CLINIC DEPLOYMENT
TAIZHOU, China, Jan. 08, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements ("TCMHS"), today announced the launch of a Strategic Artificial Intelligence (AI) Insights Initiative.
China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq's Minimum Bid Price Rule
TAIZHOU, China, Oct. 26, 2023 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"), (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements ("TCMHS"), today announced that on October 19, 2023, NASDAQ notified us that it has determined that for the 10 consecutive business days, from October 5, 2023 to October 13, 2023, the closing bid price of the Company's ordinary shares has been at $1.00 per share or greater. Accordingly, the Company has regained compliance with Listing Rule 5550(a)(2) and NASDAQ has closed this matter.
China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split
Ordinary Shares Will Begin Trading on a Split-Adjusted Basis on October 5, 2023 Ordinary Shares Will Begin Trading on a Split-Adjusted Basis on October 5, 2023
Why Is China SXT Pharmaceuticals (SXTC) Stock Up 24% Today?
China SXT Pharmaceuticals (NASDAQ: SXTC ) stock is heading higher on Thursday even without any news from the pharmaceutical company. There's no recent news from China SXT Pharmaceuticals that explains today's rally.
Why Is China SXT Pharmaceuticals (SXTC) Stock Up 110% Today?
China SXT Pharmaceuticals (NASDAQ: SXTC ) stock is rocketing higher on Monday despite a lack of news from the pharmaceutical company. The Chinese pharmaceutical company hasn't released any new news or filings that explain today's rise.
China SXT Pharmaceuticals (SXTC) Stock: 1-For-20 Reverse Split Goes Into Effect
A 1-for-20 reverse split of the China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) stock has gone into effect. These are the details.
Why Is China SXT Pharmaceuticals (SXTC) Stock Up Today?
SXTC stock is soaring higher on no company-specific news. Positive developments between the U.S. and China may be fueling gains.
China SXT Pharmaceuticals Stock (SXTC): Why The Price Substantially Went Down Today
The stock price of China SXT Pharmaceuticals Inc (NASDAQ: SXTC) fell by over 45% pre-market today. This is why it happened.
SXTC Stock Increases Over 40% Intraday: Details You Should Know
The stock price of China SXT Pharmaceuticals Inc (NASDAQ: SXTC) increased by over 40% during intraday trading. These are some details you should know.
SXTC Stock Price Increased Over 20% Pre-Market: Why It Happened
The stock price of China SXT Pharmaceuticals Inc (NASDAQ: SXTC) has increased by over 20% pre-market. This is why it happened.
SXTC Stock Price Increases Over 200% Pre-Market: Why It Happened
The stock price of China SXT Pharmaceuticals (NASDAQ: SXTC) is trading at over 200% pre-market. This is why it happened.
SXTC Stock Price Increases Over 10% Pre-Market: Why It Happened
The stock price of China SXT Pharmaceuticals Inc (NASDAQ: SXTC) is trading at over 10% pre-market today. This is why it happened.
Is China SXT Pharmaceuticals, Inc. (SXTC) A Good Stock To Buy?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of capital and have to conduct due diligence while choosing their next pick. They don't always get it right, but, on average, their stock picks historically generated strong returns after adjusting for known risk factors. With this in mind, let's take a look at the recent hedge fund activity surrounding China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC).